editasmedicine.com (EDIT) - Total pendapatan perusahaan

Lambang korporat lan logo editasmedicine.com (EDIT)

Editas Medicine, Inc. (EDIT) relies on scalable CRISPR systems with high margin potential. The company diversifies its risks by developing treatments for blood and vision disorders. However, the lack of revenue and high R&D expenses make the business dependent on clinical trials. The company's sales performance clearly demonstrates this stage of development, and the value of 0.05 captures this metric.

Editas Medicine, Inc. - Pendapatan lan volume dodolan EDIT (periode 04.07.2022 - 18.11.2026)

Rincian metrik komprehensif lan analitis Editas Corp (EDIT)

Analisis komprehensif perusahaan:Editas Medicine, Inc. EDIT
Produk mawa merek Editas

The indicator is based on daily revenue aggregation, capturing the actual cash inflow from product sales. This metric determines the financial stability of the business during periods of market downturns and cooling demand. For Editas Medicine, Inc. (EDIT), which focuses on R&D and production outsourcing, these data reflect the efficiency of patent monetization. Operational dependence on vendors makes this flow critically important. By analyzing the company's total sales volume, an investor assesses the real commercial viability of the biotechnological asset.

Pesaing wigati

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Twist Bioscience Corp TWST|Pendapatan lan volume dodolan TXG|Pendapatan lan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Dodolan perusahaan|BioLife Solutions Inc (BLFS) - Total pendapatan perusahaan|wavelifesciences.com - Pendapatan lan volume dodolan|Maze Therapeutics Corp (MAZE) - Dodolan perusahaan|SION: Pendapatan lan volume dodolan|Volume dodolan perusahaan PRME|Pendapatan perusahaan Taysha Gene Therapies|Volume dodolan perusahaan QURE (uniQure)|Pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Volume dodolan perusahaan|Pendapatan perusahaan Solid Biosciences SLDB|OCGN - Dodolan perusahaan|pacb.com - Pendapatan lan volume dodolan|Benitec (BNTC) - Dodolan perusahaan|DSGN: Pendapatan lan volume dodolan|RCKT - Pendapatan reged perusahaan|FDMT: Pendapatan reged perusahaan|Volume dodolan perusahaan LXEO (lexeotx.com)|Pendapatan perusahaan Korro Bio Inc. (KRRO)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan